Clinical Trial Detail

NCT ID NCT02060370
Title Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

clear cell renal cell carcinoma

Therapies

Sunitinib

Age Groups: adult senior

No variant requirements are available.